health

A Texas A&M University expert explains the health benefits of the supplement.

Developed by biopharmaceutical company Ultragenyx, GTX-102 is the first clinically developed drug targeting the genetic causes of Angelman syndrome rather than symptoms.

A new platform mimics various blood vessel structures, enabling more accurate models of vascular disease and patient-specific research.

Supported by almost $4 million in new funding, researchers in the Texas A&M College of Veterinary Medicine and Biomedical Sciences and University of Georgia are working to develop interventions that will impact both canine and human health.

The visit highlighted the role of agriculture in improving health.

Texas A&M researchers find a strong association between urinary arsenic levels and key indicators of kidney damage.

Texas A&M experts say healthy habits centered around exercise, nutrition and rest can lead to a stronger heart.

A new pilot study is one of the first to assess how caregivers use these devices and their opinions of them.

Only one state has adopted a similar approach to cancer care as one first proposed by a Texas A&M University professor.

What to know about the allergy-inducing pollen.